Education
About Us
Working with TipRanks
Follow Us
Nordicus Partners (NORD)
OTHER OTC:NORD
NORD Stock Chart & Stats
$5.00
$0.15(1.71%)
At close: 4:00 PM EST
$5.00
$0.15(1.71%)
Day’s Range― - ―
52-Week Range$1.25 - $10.17
Previous CloseN/A
Volume450.00
Average Volume (3M)847.00
Market Cap
$80.40M
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta-0.43
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.39
Shares Outstanding17,866,550
10 Day Avg. Volume616
30 Day Avg. Volume847
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Nordicus Partners News
NORD FAQ
What was Nordicus Partners’s price range in the past 12 months?
Nordicus Partners lowest stock price was $1.25 and its highest was $10.17 in the past 12 months.
What is Nordicus Partners’s market cap?
Nordicus Partners’s market cap is $80.40M.
When is Nordicus Partners’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Nordicus Partners’s earnings last quarter?
Currently, no data Available
Is Nordicus Partners overvalued?
According to Wall Street analysts Nordicus Partners’s price is currently Overvalued.
Does Nordicus Partners pay dividends?
Nordicus Partners does not currently pay dividends.
What is Nordicus Partners’s EPS estimate?
Nordicus Partners’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Nordicus Partners have?
Nordicus Partners has 17,866,550 shares outstanding.
What happened to Nordicus Partners’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Nordicus Partners?
Currently, no hedge funds are holding shares in NORD
Company Description
Nordicus Partners
AdvanSource Biomaterials Corp. engages in the development of polymer materials, which provides characteristics in the design and development of medical devices. Its biomaterials are used in devices that are designed for treating a range of anatomical sites and disease states. The firm's products include ChronoFlex, ChronoSil, HydroMed, HydroThane, and PolyBlend. The company was founded in 1993 and is headquartered in Wilmington, MA.
Technical Analysis
Ownership Overview
Options Prices
Currently, No data available
---